Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Thromb Res. 2020 Jan 7;187:9–17. doi: 10.1016/j.thromres.2020.01.002

Figure 2. Survival functions of progression free survival according to dichotomized biomarkers.

Figure 2

y-axis: cumulative progression free survival in percent (%), x-axis: progression free survival (time from study inclusion to progression of disease) in months; continuous line: survival function of patients with biomarker ≤75th percentile; dotted line: survival function of patients with biomarker >75th percentile; crosses indicate data censoring